期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰岛素类似物对2型糖尿病患者血浆同型半胱氨酸的影响 被引量：3

原文传递
导出
摘要 目的通过检测血浆同型半胱氨酸等项目观察两种胰岛素类似物治疗2型糖尿病的临床疗效。方法将81例2型糖尿病患者随机分为2组:A组单纯应用胰岛素类似物诺和锐30治疗,B组单纯应用胰岛素类似物优泌乐25治疗。3个月后观察2组患者血浆总同型半胱氨酸(tHcy)、空腹血糖(FBG)、餐后2h血糖(P2hBG)和糖化血红蛋白A1c(HbA1c)及体质指数(BMI)情况。结果(1)治疗后2组tHcy、FBG、P2hBG、HbA1c均低于治疗前(P均<0.05)。(2)两种胰岛素类似物治疗后各指标的比较差异无统计学意义(P均>0.05)。结论胰岛素类似物治疗2型糖尿病血糖控制明显,且血浆tHcy水平也明显下降。
作者 隋晓婵 杜以武 杨春杰
机构地区 吉林大学第四医院内分泌科
出处 《中国临床研究》 CAS 2010年第5期378-379,共2页 Chinese Journal of Clinical Research
关键词 2型糖尿病 胰岛素类似物 血浆同型半胱氨酸 血糖 糖化血红蛋白
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献8

  • 1Emoto M, Kanda H, Shoji T, et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes [J]. Diabetes Care, 2001,24 ( 3 ) :533 - 538.
  • 2Pongchaidecha M, Srikusalanukul V, Chattananon A, et al. Effect of mefformin on plasma homocysteine,vitamin B12 and folic acid:a cross- sectional study in patients with type 2 diabetes mellitus[J]. J Med Assoc Thai,2004,87 (7) :780 -787.
  • 3Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease ,especially in non-insulin dependent diabetes mellitus: a population-based study[J].Arterioscler Thromb Vasc Biol, 1998,18 ( 1 ) : 133 - 138.
  • 4Montalescot G, Ankri A, Chadefaux-Vekemans B, et al. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease[J].Int J Cardiol,1997,60(3) :295 -300.
  • 5Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocyst (e) inemia and endothelial dysfunction in IDDM [J].Diabetes Care, 1997,20 (12) : 1880 - 1886.
  • 6Fonseca VA, Mudaliar S, Schmidt B, et al. Plasma homocysteine concentrations are regulated by acute hyperlnsulinemia in nondiabetic but not type 2 diabetic subjects[J]. Metabolism, 1998,47 (6) :686 -689.
  • 7Goodall G, Jcndle JH, Valentine WJ, et al. Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naive type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting[J]. Int J Clin Pract,2008,62(6) :869 - 876.
  • 8崔岱,刘超.预混胰岛素在糖尿病治疗中的现状[J].国际内科学杂志,2009,36(1):19-22. 被引量：11

二级参考文献21

  • 1Malone JK, Woodworth JR, Arora V, et al. hnproved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus. Clin Ther, 2000, 22(2):222-230.
  • 2Herz M, Arora V, Campaigne BN, et al. Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus. S Afr Med J, 2003, 93(3) :219-223.
  • 3Coscelli C, Iacobellis G, Calderini C, et al. Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits. Acta Diabetol, 2003, 40(4) :187-192.
  • 4Mattoo V, Milicevic Z, Malone JK, et al. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes Res Clin Pract, 2003, 59(2) :137-143.
  • 5Schwartz S, Zagar A J, Ahhouse SK, et al. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus. Clin Ther, 2006, 28 (10) : 1649-1657.
  • 6Sun P, Wang R, Jacober S. The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin. Curr Med Res Opin, 2007, 23(12) :3017-3023.
  • 7Malone JK, Kerr LF, Campaigne BN, et al. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clin Ther, 2004, 26(12) :2034-2044.
  • 8Malone JK, Bai S, Campaigne BN, et al. Twice-daily premixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes. Diabet Med, 2005, 22(4) :374-381.
  • 9Roac H, Koledova E, Metcalfe S, et al. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide. Clin Ther, 2001, 23 ( 10 ) : 1732- 1744.
  • 10Jacobsen LV, Sogaard B, Riis A. Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart. Eur J Clin Pharmacol,2000, 56(5) :399-403.

共引文献10

同被引文献34

引证文献3

二级引证文献7

中国临床研究
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部